Item

Response to 'letter to editor-in-chief' and 'redefining resectability: bridging perspectives in stage III NSCLC management'

Houda, I.
Bahce, I.
Remon, J.
Berghmans, T.
Faivre-Finn, C.
Dingemans, A. C.
Besse, B.
Hendriks, L. E. L.
Citations
Google Scholar:
Altmetric:
Abstract
Affiliation
Department of Pulmonary Medicine, Amsterdam UMC, Location VU Medical Center, Cancer Center Amsterdam, de Boelelaan 1117, Amsterdam 1081HV, the Netherlands. Electronic address: i.houda@amsterdamumc.nl. Department of Pulmonary Medicine, Amsterdam UMC, Location VU Medical Center, Cancer Center Amsterdam, de Boelelaan 1117, Amsterdam 1081HV, the Netherlands. Electronic address: i.bahce@amsterdamumc.nl. Department of Medical Oncology, Gustave Roussy, 114 Rue Edouard Vaillant, Villejuif 94805, France. Electronic address: jordi.remon-masip@gustaveroussy.fr. Department of Medical Oncology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Mijlenmeersstraat 90, Brussels 1070, Belgium. Electronic address: thierry.berghmans@hubruxelles.be. Department of Radiation Oncology, The Christie NHS Foundation Trust, Wilmslow Rd, Manchester M20 4BX, United Kingdom; University of Manchester, Oxford Rd, Manchester M13 9PL, United Kingdom. Electronic address: corinne.finn@nhs.net. Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Dr. Molewaterplein 40, Rotterdam 3015 GD, the Netherlands. Electronic address: a.dingemans@erasmusmc.nl. Department of Medical Oncology, Gustave Roussy, 114 Rue Edouard Vaillant, Villejuif 94805, France. Electronic address: benjamin.besse@gustaveroussy.fr. Department of Pulmonary Medicine, GROW - School for Oncology and Reproduction, Maastricht University Medical Center+, P. Debyelaan 25, Maastricht 6229 HX, the Netherlands. Electronic address: lizza.hendriks@mumc.nl.
Description
Date
2025
Publisher
Keywords
Type
Correspondence
Citation
Houda I, Bahce I, Remon J, Berghmans T, Faivre-Finn C, Dingemans AC, et al. Response to "Letter to Editor-in-Chief" and "Redefining Resectability: Bridging Perspectives in Stage III NSCLC Management". Lung cancer (Amsterdam, Netherlands). 2025 May;203:108510. PubMed PMID: 40153964. Epub 2025/03/29. eng.
Journal Title
Journal ISSN
Volume Title
Embedded videos